Alumis

Alumis

Pharmaceuticals

Company website
Foundation year

2021

About

Alumis is dedicated to significantly enhancing patient lives by transitioning from broad immunosuppression to precise therapies. The name "Alumis" reflects this commitment, deriving from the French word "allumer" meaning to illuminate, and "immunis," the Latin term for the immune system.

Underwriters

Morgan Stanley, Leerink, Cantor, Guggenheim Securities


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.